X Series®, R Series®, AED Pro®, AED 3™ BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower™

Automated External Defibrillators (non-wearable)

FDA Premarket Approval P160022

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the x series defibrillator function. The x series system is indicated for defibrillation on victims of cardiac arrest where there is apparent lack of circulation as indicated by:1) unconsciousness;2) absence of breathing; and3) absence of pulsethe x series system in the manual mode is indicated for synchronized cardioversion of certain atrial or ventricular arrhythmias. A qualified physician must decide when synchronized cardioversion is appropriate. The x series system semiautomatic and manual mode is indicated for use in early defibrillation programs where the delivery of a defibrillator shock during resuscitation involving cpr, transportation, and definitive care are incorporated into a medically-approved patient care protocol. The x series system semiautomatic and manual mode is indicated for adult and pediatric patients. R series defibrillator functionthe r series system is indicated for defibrillation on victims of cardiac arrest where there is apparent lack of circulation as indicated by:1) unconsciousness;2) absence of breathing; and3) absence of pulse. The r series system in the manual mode is indicated for synchronized cardioversion of certain atrial or ventricular arrhythmias. A qualified physician must decide when synchronized cardioversion is appropriate. The r series system semiautomatic and manual mode is indicated for use in early defibrillation programs where the delivery of a defibrillator shock during resuscitation involving cpr, transportation, and definitive care are incorporated into a medically-approved patient care protocol. The r series system semiautomatic and manual mode is indicated for adult and pediatric patients. Aed prothe aed pro system is indicated for use on victims of cardiac arrest with apparent lack of circulation as indicated by:1) unconsciousness;2) absence of breathing; and3) absence of pulse and other signs of circulation. The device is also indicated for use when ecg monitoring is indicated to evaluate the patient’s heart rate or ecg morphology. The aed pro system is indicated for adult and pediatric patients. Aed 3 blsthe zoll aed 3 system is indicated for use when a suspected cardiac arrest victim has an apparent lack of circulation as indicated by:1) unconsciousness;2) absence of breathing; and3) absence of pulse and other signs of circulation. The aed 3 system is indicated for adult and pediatric patients. ...

DeviceX Series®, R Series®, AED Pro®, AED 3™ BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower™
Classification NameAutomated External Defibrillators (non-wearable)
Generic NameAutomated External Defibrillators (non-wearable)
ApplicantZOLL MEDICAL CORPORATION
Date Received2016-07-07
Decision Date2017-12-27
Notice Date2018-01-09
PMAP160022
SupplementS
Product CodeMKJ
Docket Number17M-7004
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address ZOLL MEDICAL CORPORATION 269 & 271 Mill Road chelmsford, MA 01824-4105
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P160022Original Filing
S028 2021-04-23 Normal 180 Day Track No User Fee
S027 2021-03-15 30-day Notice
S026 2021-02-24 30-day Notice
S025 2020-12-21 30-day Notice
S024 2020-12-17 30-day Notice
S023 2020-11-24 30-day Notice
S022 2020-09-16 30-day Notice
S021 2020-09-14 30-day Notice
S020
S019
S018 2020-05-29 30-day Notice
S017
S016
S015
S014
S013
S012 2019-07-26 30-day Notice
S011 2019-05-13 Real-time Process
S010 2019-04-08 Real-time Process
S009 2019-03-19 30-day Notice
S008
S007 2018-08-10 Real-time Process
S006 2018-06-07 Real-time Process
S005 2018-06-07 Real-time Process
S004 2018-05-18 Real-time Process
S003 2018-04-30 30-day Notice
S002 2018-04-30 30-day Notice
S001 2018-01-16 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.